Log in to save to my catalogue

Correction: Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carci...

Correction: Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carci...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11098856

Correction: Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma using contrast-enhanced ultrasonography

About this item

Full title

Correction: Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma using contrast-enhanced ultrasonography

Publisher

Singapore: Springer Nature Singapore

Journal title

Journal of medical ultrasonics (2001), 2024-04, Vol.51 (2), p.387-387

Language

English

Formats

Publication information

Publisher

Singapore: Springer Nature Singapore

More information

Alternative Titles

Full title

Correction: Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma using contrast-enhanced ultrasonography

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11098856

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11098856

Other Identifiers

ISSN

1346-4523,1613-2254

E-ISSN

1613-2254

DOI

10.1007/s10396-024-01430-2

How to access this item